CELMoDs Tomorrow

A panel of experts explore the potential of next-generation #myeloma treatments, focusing on Cereblon E3 ligase modulators (CELMoDs) and the critical need for equitable patient access. The panel includes: Dana…

Immunomodulators (IMDs) Today

A panel of experts discuss the bedrock therapy in multiple myeloma immunomodulators (IMDs). The panel includes: Jenny Ahlstrom – Founder and Chief Executive Officer, Healthtree Foundation Diane Moran – Business…

Tailored Multiple Myeloma Care

A panel of experts discuss strategies for how to best support multiple myeloma patients and their families during treatment. The panel includes: Diane Moran – Business Relationship Management, International Myeloma…

Can Self-Advocacy Close the Gap in Bladder Cancer Outcomes?

https://vimeo.com/1062233283 Bladder cancer research insights show disparities for specific groups. Expert Dr. Shaakir Hasan from Beth Israel Lahey Health discusses highlights from his research study, the value of seeking medical attention and…

When Is Immunotherapy Recommended in Bladder Cancer?

https://vimeo.com/1060749973 Bladder cancer immunotherapy is available, but which patients qualify for it? Expert Dr. Shaakir Hasan from Beth Israel Lahey Health discusses who is eligible for immunotherapy, patient factors that contraindicate against…

Share On:

Facebook
Twitter
LinkedIn